1. Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis
- Author
-
John G. Zampella, Abhishek Gami, Manisha J. Loss, Chikoti M. Wheat, and Judy Doong
- Subjects
medicine.medical_specialty ,Thymoma ,ECP, extracorporeal photopheresis ,extracorporeal photopheresis ,medicine.medical_treatment ,Case Report ,chemical and pharmacologic phenomena ,Dermatology ,GVHD, graft-versus-host disease ,medicine.disease_cause ,Gastroenterology ,Autoimmunity ,Prednisone ,hemic and lymphatic diseases ,Internal medicine ,Extracorporeal Photopheresis ,IVIg, intravenous immunoglobulin ,medicine ,immunosuppression ,business.industry ,autoimmunity ,Multimodal therapy ,Immunosuppression ,thymoma ,medicine.disease ,TAMA, thymoma-associated multiorgan autoimmunity ,thymoma-associated multiorgan autoimmunity ,Radiation therapy ,surgical procedures, operative ,Graft-versus-host disease ,RL1-803 ,business ,medicine.drug - Abstract
Patients with malignant thymomas are susceptible to the development of graft-versus-host disease (GVHD)–like disease known as thymoma-associated multiorgan autoimmunity (TAMA). The proposed mechanism of this paraneoplastic phenomenon is a breakdown in the immune regulatory function of the thymus and subsequent activation of T cells. Here, we report a novel case of a patient with TAMA who, following surgical resection and radiation therapy, successfully underwent treatment with a combination of extracorporeal photopheresis (ECP), intravenous immunoglobulin (IVIg), cyclosporine, and prednisone.
- Published
- 2021